Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2018 4
2019 3
2020 5
2021 3
2022 1
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for hajkova n
Search for Haytova N instead (1 results)
Gynecological lesions in hereditary cancer predisposition syndromes.
Dundr P, Cibula D, Foretová L, Macek M Jr, Kopečková K, Petruželka L, Němejcová K, Bártů M, Hojný J, Hájková N, Jakša R, Janega P, Stružinská I. Dundr P, et al. Among authors: hajkova n. Cesk Patol. 2021 Summer;57(2):96-104. Cesk Patol. 2021. PMID: 34275319 Review. English.
A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.
Stružinská I, Hájková N, Hojný J, Krkavcová E, Michálková R, Dvořák J, Němejcová K, Matěj R, Laco J, Drozenová J, Fabian P, Hausnerová J, Méhes G, Škapa P, Švajdler M, Cibula D, Frühauf F, Bártů MK, Dundr P. Stružinská I, et al. Among authors: hajkova n. Diagn Pathol. 2023 Jun 12;18(1):72. doi: 10.1186/s13000-023-01358-0. Diagn Pathol. 2023. PMID: 37303048 Free PMC article.
HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.
Kendall Bártů M, Němejcová K, Michálková R, Stružinská I, Hájková N, Hojný J, Krkavcová E, Laco J, Matěj R, Drozenová J, Méhes G, Fabian P, Hausnerová J, Švajdler M, Škapa P, Cibula D, Zima T, Dundr P. Kendall Bártů M, et al. Among authors: hajkova n. Virchows Arch. 2023 Oct;483(4):497-507. doi: 10.1007/s00428-023-03640-4. Epub 2023 Sep 7. Virchows Arch. 2023. PMID: 37676270
Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories.
Dundr P, Bártů M, Bosse T, Bui QH, Cibula D, Drozenová J, Fabian P, Fadare O, Hausnerová J, Hojný J, Hájková N, Jakša R, Laco J, Lax SF, Matěj R, Méhes G, Michálková R, Šafanda A, Němejcová K, Singh N, Stolnicu S, Švajdler M, Zima T, Stružinská I, McCluggage WG. Dundr P, et al. Among authors: hajkova n. Mod Pathol. 2023 Jan;36(1):100040. doi: 10.1016/j.modpat.2022.100040. Mod Pathol. 2023. PMID: 36788074 Free article.
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes.
Hájková N, Bártů MK, Cibula D, Drozenová J, Fabian P, Fadare O, Frühauf F, Hausnerová J, Hojný J, Krkavcová E, Laco J, Lax SF, Matěj R, Méhes G, Michálková R, Němejcová K, Singh N, Stolnicu S, Švajdler M, Zima T, McCluggage WG, Stružinská I, Dundr P. Hájková N, et al. Transl Res. 2023 Oct;260:61-68. doi: 10.1016/j.trsl.2023.05.004. Epub 2023 May 25. Transl Res. 2023. PMID: 37244485 Free article.
Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance.
Dundr P, Hájková N, Kendall Bártů M, Cibula D, Drozenová J, Fabian P, Fadare O, Frühauf F, Hausnerová J, Hojný J, Laco J, Lax SF, Matěj R, Méhes G, Michálková R, Němejcová K, Singh N, Stolnicu S, Švajdler M, Zima T, McCluggage WG, Stružinská I. Dundr P, et al. Among authors: hajkova n. Pathology. 2023 Oct;55(6):785-791. doi: 10.1016/j.pathol.2023.04.008. Epub 2023 Jul 11. Pathology. 2023. PMID: 37500307
Comprehensive Analysis of PTEN in Primary Cutaneous Melanoma.
Němejcová K, Dundr P, Jakša R, Bártů M, Stružinská I, Hojný J, Hájková N, Kodet O. Němejcová K, et al. Among authors: hajkova n. Folia Biol (Praha). 2020;66(1):7-16. Folia Biol (Praha). 2020. PMID: 32512654 Free article.
Germline mutation in the TP53 gene in uveal melanoma.
Hajkova N, Hojny J, Nemejcova K, Dundr P, Ulrych J, Jirsova K, Glezgova J, Ticha I. Hajkova N, et al. Sci Rep. 2018 May 16;8(1):7618. doi: 10.1038/s41598-018-26040-0. Sci Rep. 2018. PMID: 29769598 Free PMC article.
HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study.
Dundr P, Bártů M, Hojný J, Michálková R, Hájková N, Stružinská I, Krkavcová E, Hadravský L, Kleissnerová L, Kopejsková J, Hiep BQ, Němejcová K, Jakša R, Čapoun O, Řezáč J, Jirsová K, Franková V. Dundr P, et al. Among authors: hajkova n. Sci Rep. 2020 Sep 1;10(1):14365. doi: 10.1038/s41598-020-71427-7. Sci Rep. 2020. PMID: 32873863 Free PMC article.
22 results